Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors

Paul Bamborough, Chun‐wa Chung, Rebecca C. Furze, Paola Grandi, Anne‐Marie Michon, Robert J. Sheppard, Heather Barnett, Hawa Diallo, David P. Dixon, Clement Douault,

Journal of Medicinal Chemistry · 2015 · 83 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

ATAD2 is a bromodomain-containing protein whose overexpression is linked to poor outcomes in a number of different cancer types. To date, no potent and selective inhibitors of the bromodomain have been reported. This article describes the structure-based optimization of a series of naphthyridones from micromolar leads with no selectivity over the BET bromodomains to inhibitors with sub-100 nM ATAD2 potency and 100-fold BET selectivity.

References

23